-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Trials and Tribulations - Autologous and 3rd Party EBV T Cell Immunotherapy

Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
Program: Scientific Workshops
Session: Anti-Viral Cellular Immunotherapies
Friday, December 8, 2023, 4:13 PM-4:53 PM

Rayne Rouce, MD

Texas Children's Hospital, Houston, TX

Disclosures: Rouce: Pfizer: Consultancy; Novartis: Honoraria; Tessa Therapeutics: Research Funding.

See more of: Anti-Viral Cellular Immunotherapies
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation